Stronger Patents Act – Back Again By Scott McKeown on

New Post Public Reply Private Reply Replies (0) Message Board
CyberC gimli #56717
448
Stronger Patents Act – Back Again
By Scott McKeown on July 12, 2019

2015, 2017, 2018, 2019…
The Stronger Patents Act just wont go away. While the bill has been introduced several times over the years, it has never gotten any significant traction. Since its initial introduction, several of the bill’s Patent Trial & Appeal Board (PTAB) provisions have been mooted by regulatory changes. What remains would effectively repeal the AIA to the point that the PTAB would no longer be a viable option — a non-starter for everyone but Bio/Pharma and small inventors.

So, what is different now?

Simply stated, the bill hasn’t really changed much at all. The sponsors may sense an opportunity for the STRONGER Patents Act to ride the coattails of current 101 momentum. But, more than likely this bill is serving as a foil to opponents of 101 change (i.e., Big Tech). Given the choice between the two, 101 reform is far more palatable to Big Tech.

Patent reform political theater will continue this summer with a draft 101 bill expected within the month. Stay tuned!

(For those interested in a deeper dive on some of the few changes of the STRONGER Patents Act of 2019, you can find a great summary, read the following:

STRONGER Patents—Bad Legislation
by Josh Landau • July 11, 2019
Yesterday, the STRONGER Patents Act of 2019 was introduced by Senators Chris Coons and Tom Cotton, along with a House companion bill introduced by Reps. Steve Stivers and Bill Foster. The bill looks much like the last two times it was introduced [1][2], but there have been a few changes.

What’s New
The title says 2019 instead of 2017.

What’s Old
There’ve been some minor changes, but the majority of the STRONGER Patents Act is a copy of the 2017 edition.

That means that the bill still creates a standing requirement for inter partes reviews (IPRs), incentivizing patent owners to sit and wait until products are developed and profitable before filing their lawsuits and preventing product designers from testing the validity of a patent before making that investment.

The bill still changes the standard of proof in IPRs to clear and convincing evidence–a standard district courts use in deference to the competence of the USPTO. The USPTO has no need to defer to its own competence—in fact, the multiple technically and legally trained judges composing a PTAB panel are significantly more competent than the single examiner spending an average of 19 hours to examine a patent.

It still defines a real party in interest broadly enough that a stockholder might be a real party in interest and a crowdfunder almost certainly is. The real party in interest requirement was designed to prevent a company from using control or influence with another company to file an IPR that they wouldn’t have been able to file themselves, something the PTAB already actively polices, and the amended definition of real party in interest goes far beyond that point.

It still requires a separate panel to hear an IPR after a first panel decides to institute, even though that isn’t the way district courts work when they decide threshold issues like motions to dismiss, or the way the Supreme Court works when it decides whether to grant certiorari and then decides the case. Senator Coons has frequently claimed he wants to harmonize treatment between the PTAB and the courts, but this provision actively contradicts that goal.

And the bill still makes it so that once a patent claim has been challenged once, it can never be challenged again at the PTAB, creating significant incentives for collusive petitions—a very real threat given the multiple attempts by patent owners to use tribal sovereign immunity to shield their petitions, a threat only recently ended.

Senator Coons hasn’t updated the factual findings, either, still claiming that the strategy of filing IPRs to try to short a stock is a threat—even though the one entity that ever tried that strategy failed and quit.

So that’s what’s old. What’s changed?

What’s Different
There have been a few minor improvements to the 2017 bill—almost entirely made by removing portions of the bill. The provision on appeal from institution decisions no longer permits interlocutory appeals against institution, though it still provides for a wider range of appeal of institution decisions compared to non-institution decisions, biasing the IPR process even further against challenges to invalid patents. And the unnecessarily complex and easily abused amendment off-ramp procedure that the 2017 bill proposed is gone.

The 2019 bill also eliminates some of the more significant bad ideas that were part of the 2017 edition. The ill-conceived provision that would have incentivized sending research and development overseas has been removed. And the companion provision that would have eliminated the knowledge element of induced infringement is also gone, preserving a century of patent precedent and making sure that you aren’t liable for inducing infringement of a cellular patent just because you texted someone and it caused their phone to operate in an infringing way.

But even the improvements are just eliminating harmful changes from the bill—they don’t actively improve the patent system and they don’t offset the harms to innovation that the bill would create. The STRONGER Patents Act of 2019 is not a bill that anyone should support if they care about U.S. innovation—a fire that only destroys your kitchen is better than a fire that burns down your entire house, but neither one is desirable.

Over the past 7 years, IPR has provided a successful tool to eliminate patents that shouldn’t have been granted, resulting in lower-cost, less-frequent patent litigation, saving billions of dollars that can be spent on actual research and development instead of lawyers. And the reduction in litigation has come almost entirely from non-practicing entities, not the kind of productive operating companies that perform research and development.

Why would anyone want a bill that tries so hard to eliminate a program that’s eliminated patents that never should have issued, reduced the amount of troll litigation, and even made litigation less expensive in the process?



Zerify Inc (ZRFY) Stock Research Links

ZRFY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sidus Gains Argotec Order, but Investors Need the Math

Updated Category News Views 161

A Real Customer Signal, Minus the Revenue Figure An updated image is the least interesting detail in this release. Sidus Space has landed a purchase order from Argotec Group to manufacture cable assemblies for the HAWK satellite platform, with delivery expected in the first quarter of 2027. That is a legitimate operational win for NASDAQ:SIDU. It brings in a new...

Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 78

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
Cottage Grove Tests Holiday Demand Across Lake Norman

Updated Category News Views 139

Flour and foot traffic make a pretty honest little scoreboard. Cottage Grove Bakery is putting itself in front of Lake Norman shoppers twice on Saturday, November 21, while also taking Thanksgiving orders and laying groundwork for 2027 workplace and school visits. This is not a public-company earnings story, and nobody should pretend a tray of scones is a quarterly...

Continue Reading
California Initiative Puts Missed Diagnoses in Focus

Updated Category News Views 161

When Reassurance Turns Into a Risk A clean scan can become a dangerous lullaby when symptoms refuse to leave. That is the hard, unsettling territory behind Hodes Milman’s new Missed Diagnosis Project: California, launched November 20, 2026. The statewide effort focuses on breast cancer diagnostic failures: scans read as benign when more scrutiny was warranted, referrals...

Continue Reading
Highmark’s 2026 Rebound Has a Few Asterisks Attached

Updated Category News Views 74

The Headline Needs a Pencil, Not a Highlighter A $1.9 billion net-income figure can look downright thunderous until you separate the cash-generating engine from the accounting cargo strapped to it. Highmark Health reported $26.5 billion in revenue and $741 million in operating income for the nine months ended Sept. 30, 2026. Those are materially better numbers than the...

Continue Reading
Domino's Probe Puts Franchise Disclosure Under Lens

Updated Category News Views 139

A franchisee's shuttered stores can turn cheerful unit-growth talk into a nasty accounting of credibility, and that is the uncomfortable territory Domino's now occupies. Kahn Swick & Foti has opened an investigation into whether Domino's officers and directors breached fiduciary duties or violated state or federal law. That is not a finding of misconduct. It is a legal...

Continue Reading
ModuleMD Takes Allergy EHR AI Beyond the Usual Hype Cycle

Updated Category News Views 121

Allergy Workflows Are Where This Has to Earn Its Keep Allergy clinics do not need another shiny dashboard clogging up a workstation. They need less typing, fewer handoffs, cleaner documentation, and fewer administrative chores slipping through the cracks while a packed day keeps moving. That is the practical lens for ModuleMD's ACAAI 2026 presentation in Phoenix: not...

Continue Reading
QuidelOrtho Faces Fresh Scrutiny Over Savanna Claims

Updated Category News Views 157

A diagnostic launch can turn into a corporate migraine with frightening speed, and QuidelOrtho is staring at exactly that sort of mess. Kahn Swick & Foti said on November 20, 2026, that it has begun investigating whether QuidelOrtho officers or directors breached fiduciary duties or otherwise violated state or federal law. This is not a finding of wrongdoing. It is an...

Continue Reading
Newegg’s GIGABYTE Event Is Brand Work, Not a Catalyst

Updated Category News Views 92

A 2,300-square-foot room can tell a retailer plenty about its tribe. On November 21, Newegg is turning its Diamond Bar Gamer Zone into the home base for GIGABYTE’s AORUS VS40 celebration, a free five-hour event marking the hardware maker’s 40th anniversary. There will be 1v1 VALORANT and League of Legends contests, demo stations, raffles, anniversary merchandise, food...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 154

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding Market Sentiment Around Primerica's Stock

Updated Category News Views 89

Market Sentiment and Primerica's Stock Insights Primerica (NYSE: PRI) has seen a notable change in its short interest recently. The short percent of float has decreased by 11.7% since the last reporting period, indicating a shift in trader sentiment. Currently, there are approximately 219 thousand shares sold short, which accounts for about 0.83% of all regular shares...

Continue Reading
Applied Digital Corporation Secures Major $5 Billion Contract

Updated Category News Views 189

Applied Digital Corporation Celebrates New Milestone Applied Digital Corporation (NASDAQ: APLD) has secured a transformative contract that shines a spotlight on its ambitious Polaris Forge 2 Campus project. The deal, valued at a staggering $5 billion, involves a 15-year lease agreement with a U.S.-based investment-grade hyperscaler. This significant venture is poised to...

Continue Reading
Carnival Cruise Lines on Track for Major Gains in 2025

Updated Category News Views 611

Carnival Cruise Lines Poised for Growth in 2025 Carnival Cruise Lines (NYSE: CCL) has seen a remarkable increase in its share price, rising by approximately 50% as we head into 2024. This upward trend reflects a resilient business model and robust operational efficiencies. Expectations for fiscal 2025 are bolstered by the ongoing normalization of the cruise industry...

Continue Reading
CAS Space Chairman Aims to Build Rockets Like Cars

Updated Category News Views 24

Rocket Science on the Fast Lane Welcome to a new chapter in the space race, where Yang Yiqiang of CAS Space is steering the vision. When you think of rockets, you might imagine a symphony of math and metal, far removed from the everyday grind of car production. But Yang, itching to shuffle that status quo, wants rockets rolling off assembly lines like cars—an idea...

Continue Reading
Vodafone's Strategic Cash Tender Offers Announced for 2025-2028 Bonds

Updated Category News Views 507

Vodafone Group Initiates Cash Tender Offers for Outstanding Notes Vodafone Group Plc, a prominent telecommunications company, has announced its plans to launch cash tender offers for its outstanding U.S. dollar notes due in 2025 and 2028. This strategic move is aimed at managing its debt efficiently, particularly focusing on reducing near-term maturities that could impact...

Continue Reading